Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer

by Gojayev, Anar, English, Diana P., Macer, Matthew, Azodi, Masoud
Published 2016

Robotic Repair of Uterine Dehiscence

by La Rosa, Mauricio Francisco, McCarthy, Shirley, Richter, Christine, Azodi, Masoud
Published 2013

Robotic Versus Abdominal Hysterectomy for Very Large Uteri

by Silasi, Dan-Arin, Gallo, Taryn, Silasi, Michelle, Menderes, Gulden, Azodi, Masoud
Published 2013

Robotic-Assisted Laparoscopic Hysterectomy: Outcomes in Obese and Morbidly Obese Patients

by Gallo, Taryn, Kashani, Shabnam, Patel, Divya A., Elsahwi, Karim, Silasi, Dan-Arin, Azodi, Masoud
Published 2012

Vaginal Cuff Dehiscence in Robotic-Assisted Total Hysterectomy

by Kashani, Shabnam, Gallo, Taryn, Sargent, Anita, ElSahwi, Karim, Silasi, Dan-Arin, Azodi, Masoud
Published 2012

Robot-Assisted Abdominal Cerclage During Pregnancy

by Zeybek, Burak, Hill, Amanda, Menderes, Gulden, Borahay, Mostafa A., Azodi, Masoud, Kilic, Gokhan Sami
Published 2016

Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature

by Gressel, Gregory M., Lundsberg, Lisbet S., Altwerger, Gary, Katchi, Tasleem, Azodi, Masoud, Schwartz, Peter E., Ratner, Elena S.
Published 2015

A Simple Approach to Specimen Retrieval via Posterior Colpotomy Incision

by Clark, Lindsay E., Menderes, Gulden, Tower, Amanda M., Silasi, Dan-Arin, Azodi, Masoud
Published 2015

Transvaginal Morcellation

by Clark Donat, Lindsay, Clark, Mitchell, Tower, Amanda M., Menderes, Gulden, Parkash, Vinita, Silasi, Dan-Arin, Azodi, Masoud
Published 2015

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer

by Silasi, Dan-Arin, Alvero, Ayesha B., Illuzzi, Jessica, Kelly, Michael, Chen, Rui, Fu, Han-Hsuan, Schwartz, Peter, Rutherford, Thomas, Azodi, Masoud, Mor, Gil
Published 2007

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma

by Damast, Shari, Higgins, Susan A., Ratner, Elena, De Leon, Maria C., Mani, Sheida, Silasi, Dan-Arin, Azodi, Masoud, Santin, Alessandro, Rutherford, Thomas, Schwartz, Peter E.
Published 2015

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody

by Raji, Rhoda, Guzzo, Federica, Carrara, Luisa, Varughese, Joyce, Cocco, Emiliano, Bellone, Stefania, Betti, Marta, Todeschini, Paola, Gasparrini, Sara, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter, Rutherford, Thomas J, Buza, Natalia, Pecorelli, Sergio, Santin, Alessandro D
Published 2011

Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein ta...

by Cocco, Emiliano, Varughese, Joyce, Buza, Natalia, Bellone, Stefania, Glasgow, Michelle, Bellone, Marta, Todeschini, Paola, Carrara, Luisa, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Rutherford, Thomas J, Pecorelli, Sergio, Lockwood, Charles J, Santin, Alessandro D
Published 2011

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment

by Craveiro, Vinicius, Yang-Hartwich, Yang, Holmberg, Jennie C, Sumi, Natalia J, Pizzonia, John, Griffin, Brian, Gill, Sabrina K, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Alvero, Ayesha B, Mor, Gil
Published 2013

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment

by Craveiro, Vinicius, Yang-Hartwich, Yang, Holmberg, Jennie C, Sumi, Natalia J, Pizzonia, John, Griffin, Brian, Gill, Sabrina K, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Alvero, Ayesha B, Mor, Gil
Published 2013

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro

by Ferrari, Francesca, Bellone, Stefania, Black, Jonathan, Schwab, Carlton L., Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Predolini, Federica, Menderes, Gulden, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Published 2015

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

by Black, Jonathan D, Lopez, Salvatore, Cocco, Emiliano, Bellone, Stefania, Altwerger, Gary, Schwab, Carlton L, English, Diana P, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published 2015

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

by Black, Jonathan D, Lopez, Salvatore, Cocco, Emiliano, Bellone, Stefania, Altwerger, Gary, Schwab, Carlton L, English, Diana P, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published 2015

T-DM1, a novel antibody–drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo

by English, Diana P, Bellone, Stefania, Schwab, Carlton L, Bortolomai, Ileana, Bonazzoli, Elena, Cocco, Emiliano, Buza, Natalia, Hui, Pei, Lopez, Salvatore, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Rutherford, Thomas J, Santin, Alessandro D
Published 2014

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo

by Cocco, Emiliano, Lopez, Salvatore, Black, Jonathan, Bellone, Stefania, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Schwab, Carlton L, Menderes, Gulden, Zammataro, Luca, Buza, Natalia, Hui, Pei, Wong, Serena, Zhao, Siming, Bai, Yalai, Rimm, David L, Ratner, Elena, Litkouhi, Babak, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Santin, Alessandro D
Published 2016